vimarsana.com

Page 9 - வழக்கு மேற்கு இருப்பு பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Decibel Therapeutics Appoints Dr William H Carson as Chairman of the Board of DirectorsDistinguished biopharma executive brings over 20 years of leadership in life sciences

®, the first FDA-approved digital medicine. Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts. “Bill is an eminent figure in the biopharmaceutical community with a proven track record of advancing therapies through clinical development, regulatory approval and commercialization. His appointment demonstrates our ambition to establish Decibel at the forefront of innovation in treatments to restore and improve hearing and balance,” said Laurence Reid, Ph.D., Chief Executive Officer. “Bill is passionate about delivering life-changing therapies in areas of unmet medical

Decibel Therapeutics Appoints - GuruFocus com

®, the first FDA-approved digital medicine. Bill currently serves as Chairman of the Board of Directors of OPDC and is also the Chairman of the Board of the Sozosei Foundation, a newly established Otsuka charitable organization focused on decriminalization of mental illness. He serves on the boards of Excision BioTherapeutics, Saama and Annexon Biosciences and is Trustee of the non-profit Internet2. He is Board Chair Emeritus of the Sphinx Organization, which advocates for parity and inclusion in the arts. “Bill is an eminent figure in the biopharmaceutical community with a proven track record of advancing therapies through clinical development, regulatory approval and commercialization. His appointment demonstrates our ambition to establish Decibel at the forefront of innovation in treatments to restore and improve hearing and balance,” said Laurence Reid, Ph.D., Chief Executive Officer. “Bill is passionate about delivering life-changing therapies in areas of unmet medical

Michael E Zwick Named Senior Vice President for Research

Michael E. Zwick was appointed to the position at Rutgers following a national search. Woodruff Health Sciences Center Michael E. Zwick of Emory University  will be senior vice president for research at Rutgers University, effective Sept. 1, President Jonathan Holloway and Executive Vice President for Academic Affairs Prabhas Moghe announced today. Zwick will arrive at Rutgers after serving as associate vice president for research of the Robert W. Woodruff Health Sciences Center at Emory University and the associate dean of research and professor of human genetics and pediatrics in the Emory University School of Medicine. He spent over 16 years at the Atlanta-based research institution, beginning as an assistant professor in 2005.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.